
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A. Wainberg, Colin D. Weekes, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 531-542
Open Access | Times Cited: 74
Shubham Pant, Zev A. Wainberg, Colin D. Weekes, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 531-542
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Targeting KRAS in cancer
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 14
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 14
Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
The therapeutic potential of immunoengineering for systemic autoimmunity
David A. McBride, Ryan M. Jones, Nunzio Bottini, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 203-215
Closed Access | Times Cited: 9
David A. McBride, Ryan M. Jones, Nunzio Bottini, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 203-215
Closed Access | Times Cited: 9
State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers
Scott Strum, Mads Hald Andersen, Inge Marie Svane, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8
Scott Strum, Mads Hald Andersen, Inge Marie Svane, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8
Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
Zhou Yan, Ting Zhang, Zhirong Wang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Zhou Yan, Ting Zhang, Zhirong Wang, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer
Freek R. van ‘t Land, Marcella Willemsen, Koen Bezemer, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 26, pp. 3083-3093
Open Access | Times Cited: 6
Freek R. van ‘t Land, Marcella Willemsen, Koen Bezemer, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 26, pp. 3083-3093
Open Access | Times Cited: 6
Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity
Xin Luo, Kathleen M. McAndrews, Kent A. Arian, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 550-562
Open Access | Times Cited: 6
Xin Luo, Kathleen M. McAndrews, Kent A. Arian, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 550-562
Open Access | Times Cited: 6
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 4
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 4
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access
The enhancing effect of DNA tetrahedron-based lactoferrin as an assembled adjuvant in immunotherapy
Miaomiao Xu, Tian‐Hua Zhou, Bowen Yang, et al.
Chemical Engineering Journal (2025) Vol. 506, pp. 159941-159941
Closed Access
Miaomiao Xu, Tian‐Hua Zhou, Bowen Yang, et al.
Chemical Engineering Journal (2025) Vol. 506, pp. 159941-159941
Closed Access
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access
Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Linking vaccine adjuvant mechanisms of action to function
Elana Ben‐Akiva, Asheley P. Chapman, Tianyang Mao, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Closed Access
Elana Ben‐Akiva, Asheley P. Chapman, Tianyang Mao, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Closed Access
Novel Therapeutic Strategies and Recent Advances in Gut Microbiota Synergy with Nanotechnology for Colorectal Cancer Treatment
Qinghe Han, Jie Li, Zhuo Li, et al.
Materials Today Bio (2025) Vol. 31, pp. 101601-101601
Open Access
Qinghe Han, Jie Li, Zhuo Li, et al.
Materials Today Bio (2025) Vol. 31, pp. 101601-101601
Open Access
KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy
Priyanka Uniyal, Vivek K. Kashyap, Tapan Behl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 785-785
Open Access
Priyanka Uniyal, Vivek K. Kashyap, Tapan Behl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 785-785
Open Access
J-Aggregated indocyanine green-loaded exosomes enable photoactivatable cytoplasmic delivery of STING agonist for targeted pancreatic cancer immunotherapy
Ming Li, Yifan Yang, Zhengyu Yang, et al.
Nano Today (2025) Vol. 62, pp. 102727-102727
Closed Access
Ming Li, Yifan Yang, Zhengyu Yang, et al.
Nano Today (2025) Vol. 62, pp. 102727-102727
Closed Access
Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First
Kim A. Reiss, Kevin C. Soares, Robert J. Torphy, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Kim A. Reiss, Kevin C. Soares, Robert J. Torphy, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Pancreatic Cancer: Pathogenesis and Clinical Studies
Kexun Zhou, Yingping Liu, Chuanyun Tang, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Kexun Zhou, Yingping Liu, Chuanyun Tang, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access
Administration route-commended concise organ-selective mRNA transfection (ACCOST) by cyclic disulfide-primed short polyethylenimine
Ruonan Ye, Qiang Ren, Limin Chang, et al.
Nano Today (2025) Vol. 63, pp. 102741-102741
Closed Access
Ruonan Ye, Qiang Ren, Limin Chang, et al.
Nano Today (2025) Vol. 63, pp. 102741-102741
Closed Access